Comparison Air Versus Carbon Dioxide Insufflation in Single Balloon Anterograde Enteroscopy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03811522|
Recruitment Status : Active, not recruiting
First Posted : January 21, 2019
Last Update Posted : February 15, 2019
|Condition or disease||Intervention/treatment|
|Carbon Dioxide Insufflation Anterograde Single Balloon Enteroscopy||Other: carbon dioxide insufflation Other: Air insufflation|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Comparison Air Versus Carbon Dioxide Insufflation in Single Balloon Anterograde Enteroscopy|
|Actual Study Start Date :||January 1, 2019|
|Estimated Primary Completion Date :||May 1, 2020|
|Estimated Study Completion Date :||June 1, 2020|
Carbon Dioxide Insufflation
Received CO2 insufflation during procedure
Other: carbon dioxide insufflation
Receives CO2 insufflation
Received ambient insufflation during procedure
Other: Air insufflation
Receives air insufflation
- The reduction of post operational pain [ Time Frame: the survey will be asked at 15minutes, 30minutes, 1hour, and 24hours post op. ]
Assessment of post operational pain will be made by the the horizontal assessment scale (HAS) for post operative pain. The survey will include the following questions.
- Mark your level of pain by drawing a horizontal line on the scale below.
- Rate the severity of your nausea by circling a number on the scale.
- Rate the severity of your bloating by circling a number on the scale.
Rate the severity of your abdominal fullness by circling a number on the scale.
- Note the scale was not provided given the limitation of characters.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03811522
|United States, Ohio|
|St. Joesph Health Center|
|Warren, Ohio, United States, 44484|
|Principal Investigator:||Thomas Geisler, D.O.||North Eastern Ohio Gastroenterology and Endoscopy center|